Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02769858 · ClinicalTrials.gov registry record · NA

The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT02769858: Completed NA study, sponsored by University of Michigan.

NCT02769858 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02769858, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The proposed study aims to establish the feasibility of light therapy for postpartum depression delivered via Re-Timer, demonstrate its preliminary efficacy, and illuminate relationships between circadian shifts and mood changes using a novel, home-based circadian biomarker assessment paradigm (salivary dim light melatonin onset; DLMO).

Primary Outcome

Clinician-rated depression symptom severity measure; Hamilton Depression Rating Scale-Seasonal Affective Version (SIGH-SAD) (29 item version) measures depressive symptoms on a continuous scale. Higher scores indicate worse outcomes. Scores can range from 0 -73, where 0 means no depression, and 73 is the greatest possible depression. Generally scores of 20 or higher represent clinical depression

Interventions

  • DEVICE Light therapy

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2015-06
Est. Completion 2016-12
Phase NA
University of Michigan

1,327 total trials

What the finished NCT02769858 record still lists

NCT02769858 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Light therapy is the first listed.

NCT02769858 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02769858 about?

NCT02769858 is a clinical study titled "The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression". The proposed study aims to establish the feasibility of light therapy for postpartum depression delivered via Re-Timer, demonstrate its preliminary efficacy, and illuminate relationships between circadian shifts and mood changes using a novel, home-based circadian biomarker assessment paradigm (sali...

What is the current status of trial NCT02769858?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2015-06. Estimated completion is 2016-12.

What interventions are being tested in trial NCT02769858?

The interventions under investigation include: Light therapy (DEVICE).

Who is sponsoring clinical trial NCT02769858?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02769858's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02769858, the US trial registry maintained by the National Library of Medicine. NCT02769858 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.